Nordcurrent Store

The Prostate Cancer Dilemma: Selecting Patients... Apr 2026

The dilemma in prostate cancer management lies in the fine line between lifesaving intervention and unnecessary overtreatment. While early detection can reduce mortality, standard screening methods—like the Prostate-Specific Antigen (PSA) test—often flag slow-growing, "indolent" tumors that would never have caused symptoms or harm in a patient's lifetime. This leads to , which often results in overtreatment through invasive procedures that carry significant side effects like urinary incontinence and erectile dysfunction. The Shift Toward Precision Selection

To address this dilemma, medical professionals are increasingly using a "triathlon" of advanced tools to better select patients for the right level of care: The Prostate Cancer Dilemma: Selecting Patients...

The dilemma in prostate cancer management lies in the fine line between lifesaving intervention and unnecessary overtreatment. While early detection can reduce mortality, standard screening methods—like the Prostate-Specific Antigen (PSA) test—often flag slow-growing, "indolent" tumors that would never have caused symptoms or harm in a patient's lifetime. This leads to , which often results in overtreatment through invasive procedures that carry significant side effects like urinary incontinence and erectile dysfunction. The Shift Toward Precision Selection

To address this dilemma, medical professionals are increasingly using a "triathlon" of advanced tools to better select patients for the right level of care: